B7-33 Nasal Spray – GV Pharmaceutical 6 mg

Product: B7-33 Nasal Spray – GV Pharmaceutical

Label details:

Total content: 6 mg in 10 ml

Per spray: 0.105 ml = 0.06 mg (60 mcg)

What B7-33 is

B7-33 is a relaxin-2–derived research peptide. It is studied mainly for:

Anti-fibrotic effects (scar tissue, fibrosis models)

Anti-inflammatory action

Tissue protection and repair

Potential benefits in cardiovascular and organ-protective research

It is designed to activate RXFP1 receptors with fewer side effects than full relaxin.

Dose per spray (important)

1 spray = 60 mcg

2 sprays = 120 mcg

3 sprays = 180 mcg

Common research-use dosing (not medical advice)

Typical reported research ranges:

120–300 mcg per day

Examples:

2 sprays/day → 120 mcg

4 sprays/day → 240 mcg

5 sprays/day → 300 mcg

Often taken once daily or split morning + evening.

Most users start low (120 mcg) and increase gradually if needed.

How to use (general)

Spray into the nostril (alternate nostrils for multiple sprays).

Keep head upright, do not sniff hard.

Avoid eating or drinking for 10–15 minutes after use.

How long the bottle lasts

10 ml ÷ 0.105 ml ≈ ~95 sprays total

Approximate duration:

2 sprays/day → ~47 days

4 sprays/day → ~23 days

⚠️ Disclaimer:

B7-33 is commonly sold for research purposes only and is not FDA/EMA-approved. Any human use should be discussed with a qualified healthcare professional.